The Swedish healthtech company FagerCare is opening the doors to a new era in weight loss and preventive healthcare. Modern medications, digital accessibility and a team of experienced specialists come together in an offering the market has long been missing: professional care without the hassle, without lock-in contracts and without breaking the bank.
When the new GLP-1 medications – Mounjaro, Ozempic and their counterparts – had their breakthrough, they fundamentally changed the game for weight loss. The results are well-documented and impressive. But access has long been uneven, expensive and riddled with bureaucratic obstacles. FagerCare was founded on a simple idea: to make these treatments available to those who genuinely need them, on the right terms.
The FagerCare Model
FagerCare is a digital healthcare service specialising in medical weight loss, with a focus on the latest pharmaceutical treatments. The service is directed at adults struggling with excess weight who want professional medical support – without having to join long queues, seek out expensive private clinics or commit to lengthy contracts.
The patient onboarding has been kept deliberately straightforward. A digital consultation with a licensed physician, an individual assessment and – where treatment is appropriate – a prescription. From there, the patient takes whatever next step suits them best.
One of the most distinct advantages of the model is the freedom to collect medication from any pharmacy, including online pharmacies, and thereby choose whichever option is cheapest at the time. In an era when medication prices vary considerably between providers, this can mean significant savings each year. No lock-in. No hidden fees. Just care on the patient’s terms.
Medical and Technical Backbone
FagerCare rests on solid medical and technical expertise. Dr Frida Fagerdahl is a specialist physician in family medicine with extensive experience in metabolic health. She represents the clinical core of the company, ensuring that every patient’s treatment is grounded in science and individual consideration.
Specialist Tony Fagerdahl brings deep knowledge in health and treatment methodology, contributing to the holistic view of patient wellbeing that runs through everything the company does.
Marcus Everflod, CEO of Searchminds, is responsible for FagerCare’s entire digital infrastructure. Searchminds builds and develops the company’s digital solutions – from platforms and patient flows to online visibility and presence. It is thanks to this partnership that FagerCare is able to offer a seamless and secure digital experience for patients across Europe.
Available Across Europe
FagerCare is already active in 25 European countries. This is not a plan – it is today’s reality. For those living abroad, moving between countries or simply preferring to manage their health digitally, this makes a decisive difference. Whether the patient is in Stockholm, Málaga or Milan, the same high-quality care is available.
Online Pharmacy and a Growing Service Offering
Over the coming year, FagerCare is expanding significantly. A partnership with an online pharmacy is in development and launching soon – a natural next step that further simplifies the entire chain from consultation to treatment. Alongside this, new services are being added continuously. FagerCare is a company in motion, with the ambition to constantly broaden what it can offer its patients.
Longevity – Healthspan, Not Just Lifespan
One of the most exciting dimensions of FagerCare’s offering is its growing focus on longevity – a concept that in recent years has moved from niche biohacking culture to one of medicine’s most talked-about frontiers. Longevity is about the science and practice of extending not just lifespan, but above all the healthy and active part of life – what is known as healthspan.
Through combinations of biomarker analysis, nutritional and exercise intervention, and targeted supplements and medications, the approach is preventive rather than reactive. Research in the field – led by figures such as David Sinclair and Peter Attia – suggests that ageing itself can be slowed, and that we have far more control over our biological age than previously assumed. FagerCare integrates this perspective into its work and offers patients access to longevity-focused services as a complement to primary treatments. It is about treating health as a long-term project, not merely the management of acute conditions.
An Exclusive Clinic Set to Open
Perhaps the most ambitious news is the opening of an exclusive physical and digital clinic, planned for the end of summer 2025. The clinic is aimed at patients with chronic conditions – those who have lived with pain, fatigue, autoimmune disorders or other long-term health issues and are seeking more in-depth, individualised support.
The concept is built on a conviction that under the right conditions, the body has a remarkable capacity to heal. The clinic will offer advanced assessment and tailor-made treatment plans, with the goal of not merely managing symptoms but actually addressing root causes.
The Case for FagerCare
In a landscape of healthcare options that are either hard to access, impersonal or prohibitively expensive, FagerCare offers something genuinely different. The combination of licensed medical expertise, digital accessibility, pricing flexibility and a steadily growing range of services makes the company one of the most complete options for anyone who takes their health seriously.
With operations in 31 countries, an online pharmacy on the way, an exclusive clinic in sight and a platform built by one of Europe’s most experienced digital companies – Searchminds – FagerCare is well positioned for what comes next. More information is available at Fagercare.